- Home
- NVCR vs GDRX Comparison
NVCR vs GDRX Comparison
Compare NVCR & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- GDRX
- Stock Information
- Founded
- NVCR 2000
- GDRX 2011
- Country
- NVCR Jersey
- GDRX United States
- Employees
- NVCR N/A
- GDRX N/A
- Industry
- NVCR Medical/Dental Instruments
- GDRX Retail: Computer Software & Peripheral Equipment
- Sector
- NVCR Health Care
- GDRX Technology
- Exchange
- NVCR Nasdaq
- GDRX Nasdaq
- Market Cap
- NVCR 3.0B
- GDRX 3.1B
- IPO Year
- NVCR 2015
- GDRX 2020
- Fundamental
- Price
- NVCR $30.97
- GDRX $4.50
- Analyst Decision
- NVCR Buy
- GDRX Buy
- Analyst Count
- NVCR 5
- GDRX 15
- Target Price
- NVCR $33.40
- GDRX $9.00
- AVG Volume (30 Days)
- NVCR 1.9M
- GDRX 1.1M
- Earning Date
- NVCR 10-30-2024
- GDRX 11-07-2024
- Dividend Yield
- NVCR N/A
- GDRX N/A
- EPS Growth
- NVCR N/A
- GDRX N/A
- EPS
- NVCR N/A
- GDRX N/A
- Revenue
- NVCR $577,738,000.00
- GDRX $790,385,000.00
- Revenue This Year
- NVCR $19.13
- GDRX $7.89
- Revenue Next Year
- NVCR $5.38
- GDRX $4.04
- P/E Ratio
- NVCR N/A
- GDRX N/A
- Revenue Growth
- NVCR 14.63
- GDRX 7.14
- 52 Week Low
- NVCR $11.70
- GDRX $4.09
- 52 Week High
- NVCR $34.13
- GDRX $9.26
- Technical
- Relative Strength Index (RSI)
- NVCR 60.66
- GDRX 35.95
- Support Level
- NVCR $29.85
- GDRX $4.37
- Resistance Level
- NVCR $34.13
- GDRX $4.63
- Average True Range (ATR)
- NVCR 2.00
- GDRX 0.19
- MACD
- NVCR -0.33
- GDRX 0.01
- Stochastic Oscillator
- NVCR 44.92
- GDRX 13.82
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.